TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 73 filers reported holding TANGO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $547,753 | -19.9% | 164,986 | -4.7% | 0.00% | – |
Q1 2023 | $683,595 | -74.2% | 173,062 | -52.6% | 0.00% | -100.0% |
Q4 2022 | $2,649,041 | +53.0% | 365,385 | -23.6% | 0.00% | – |
Q3 2022 | $1,731,000 | -7.7% | 478,264 | +15.5% | 0.00% | – |
Q2 2022 | $1,876,000 | -37.8% | 414,195 | +4.0% | 0.00% | -100.0% |
Q1 2022 | $3,018,000 | -40.2% | 398,185 | -13.7% | 0.00% | 0.0% |
Q4 2021 | $5,046,000 | -4.4% | 461,234 | +12.9% | 0.00% | 0.0% |
Q3 2021 | $5,278,000 | – | 408,525 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |